once-weekly semaglutide in adults with overweight or obesity Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss early trials. The potential benefit Once-Weekly Semaglutide with Lifestyle Intervention

Wegovy is more effective in clinical trials, showing greater average weight loss than Contrave

BPC-157 is a synthetic peptide fragment

Here are some examples of GLP-1 medicines

In skincare, they act as signalling molecules, communicating with skin cells and encouraging processes such as collagen production, repair and hydration

ReadyRx injectable glutathione (administered intramuscularly or subcutaneously) offers several advantages over traditional IV glutathione infusions including convenience of home administration versus required clinic visits, substantially lower cost per treatment, flexibility of administration timing to suit individual schedules, and comparable bioavailability and therapeutic efficacy to IV administration for most applications

Visit getsowell.com for physician-formulated resources